Table 1.

Baseline characteristics in CML-CP and CML-AP

Baseline characteristicsCML-CP, n = 280 (%)CML-AP, n = 105 (%)
Age (y) category
    <657069
    ≥653031
Gender
    Male5154
    Female4946
Race
    Caucasian9283
    African American57
    Asian18
    Other22
WHO performance status
    Grade 07150
    Grade 12644
    Grade 226
    Missing<11
Time since first diagnosis (mo)
    Median5775
Prior imatinib
    Imatinib-resistant6981
    Imatinib-intolerant3119
Prior highest imatinib dose
    <600 mg2816
    ≥600-<800 mg3331
    ≥800 mg4052
    Missing<10
Other prior treatment
    IFN6658
    Transplants88
Baseline CHR
    Yes34N/A
    No66